Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $215.04 million. The enterprise value is -$43.42 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 19.79 million shares outstanding. The number of shares has decreased by -17.49% in one year.
| Current Share Class | 19.79M |
| Shares Outstanding | 19.79M |
| Shares Change (YoY) | -17.49% |
| Shares Change (QoQ) | -27.83% |
| Owned by Insiders (%) | 3.03% |
| Owned by Institutions (%) | 90.09% |
| Float | 17.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.68 |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.62, with a Debt / Equity ratio of 0.06.
| Current Ratio | 22.62 |
| Quick Ratio | 22.17 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -16.79% and return on invested capital (ROIC) is -404.75%.
| Return on Equity (ROE) | -16.79% |
| Return on Assets (ROA) | -12.23% |
| Return on Invested Capital (ROIC) | -404.75% |
| Return on Capital Employed (ROCE) | -35.85% |
| Weighted Average Cost of Capital (WACC) | 8.85% |
| Revenue Per Employee | $381,402 |
| Profits Per Employee | -$978,678 |
| Employee Count | 87 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.16M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.96% in the last 52 weeks. The beta is 0.95, so KROS's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | -22.96% |
| 50-Day Moving Average | 11.37 |
| 200-Day Moving Average | 15.32 |
| Relative Strength Index (RSI) | 48.74 |
| Average Volume (20 Days) | 341,503 |
Short Selling Information
The latest short interest is 1.42 million, so 7.15% of the outstanding shares have been sold short.
| Short Interest | 1.42M |
| Short Previous Month | 1.40M |
| Short % of Shares Out | 7.15% |
| Short % of Float | 7.94% |
| Short Ratio (days to cover) | 4.14 |
Income Statement
In the last 12 months, KROS had revenue of $33.18 million and -$85.15 million in losses. Loss per share was -$2.66.
| Revenue | 33.18M |
| Gross Profit | -61.35M |
| Operating Income | -107.35M |
| Pretax Income | -90.31M |
| Net Income | -85.15M |
| EBITDA | -105.78M |
| EBIT | -107.35M |
| Loss Per Share | -$2.66 |
Full Income StatementBalance Sheet
The company has $281.50 million in cash and $16.31 million in debt, with a net cash position of $265.19 million or $13.40 per share.
| Cash & Cash Equivalents | 281.50M |
| Total Debt | 16.31M |
| Net Cash | 265.19M |
| Net Cash Per Share | $13.40 |
| Equity (Book Value) | 285.63M |
| Book Value Per Share | 14.47 |
| Working Capital | 277.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$57.20 million and capital expenditures -$1.06 million, giving a free cash flow of -$58.25 million.
| Operating Cash Flow | -57.20M |
| Capital Expenditures | -1.06M |
| Depreciation & Amortization | 1.57M |
| Net Borrowing | n/a |
| Free Cash Flow | -58.25M |
| FCF Per Share | -$2.94 |
Full Cash Flow StatementMargins
Gross margin is -184.89%, with operating and profit margins of -323.51% and -256.60%.
| Gross Margin | -184.89% |
| Operating Margin | -323.51% |
| Pretax Margin | -272.15% |
| Profit Margin | -256.60% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 17.49% |
| Shareholder Yield | 17.49% |
| Earnings Yield | -38.39% |
| FCF Yield | -26.27% |
Analyst Forecast
The average price target for KROS is $21.83, which is 100.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $21.83 |
| Price Target Difference | 100.92% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 7.54% |
| EPS Growth Forecast (5Y) | -1.14% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 9.87 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.87 |
| Piotroski F-Score | 2 |
